Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Discover which cards provide rewards without annual fees. Enjoy benefits while keeping your expenses low.
26,068 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Bitcoin climbs toward new highs as Coinbase faces regulatory headlines. This piece breaks down what it means for mass...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
With Netflix's investor update looming, investors wonder whether to buy before the release. This guide breaks down st...
Aluminum equities trade higher as supply discipline tightens and demand from aerospace and packaging stays resilient....
Private-market real estate opens access to 25,000+ multifamily units as rents rise in low-supply markets, underscorin...
FEPI’s high yield relies on aggressive call-writing against a tech-heavy basket. While payouts appear robust, scrutin...
Retirees in 2026 are turning to three dividend ETFs to secure steady cash flow while preserving growth, with SCHD, DG...
Virginia’s starting question whether its data-center incentives are delivering broad value has moved into a high-stak...
October brings more than a monthly paycheck notice. This article explores three critical updates the SSA should share...
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
The Pentagon says commercial data was used to target U.S. service members, a development that could spur tighter data...